Aso, Aurelia S.

HRN: 28-60-31  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/07/2026
03/07/2026
IV
2.25g
Q8
Nonhealing Wound
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: